Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers
  15. CDN Services

We are analyzing https://www.nature.com/articles/ncomms5280.

Title:
Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment | Nature Communications
Description:
Specific targeting and cellular internalization are key properties for carriers of antitumor therapeutic agents. Here, we develop a drug carrier through the attachment of substrate of endoprotease legumain, alanine–alanine–asparagine (AAN), to cell-penetrating peptides (TAT, trans-activating factor). The addition of the AAN moiety to the fourth lysine in the TAT creates a branched peptide moiety, which leads to a decrease in the transmembrane transport capacity of TAT by 72.65%. Legumain efficiently catalyses the release of TAT-liposome from the AAN-TAT-liposome and thereby recovers the penetrating capacity of TAT. Doxorubicin carried by the AAN-TAT-liposome led to an increase in the tumoricidal effect of doxorubicin and a reduction in its systemic adverse effects in comparison with doxorubicin carried by a control delivery system. Thus, the specific targeting and high efficiency of this delivery platform offers a novel approach to limit the toxicity of anticancer agents as well as increasing their efficacy in cancer therapy. Legumain is a protease found expressed in tumour cells and may be useful in the specific targeting of chemotherapeutics to tumour cells. Here, the authors design nanoparticles that are loaded with doxorubicin and contain a legumain cleavage site; once the nanoparticles enter tumour cells legumain activity results in the release of doxorubicin.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}


Display Ads {🎯}

$63,100 per month
Our analysis indicates Nature.com generates between $42,042 and $115,616 monthly online from display ads.

Keywords {🔍}

legumain, cells, nanoparticles, tumour, cancer, article, doxorubicin, pubmed, aantatlipo, google, scholar, cas, fig, drug, breast, analysis, cell, tat, shown, results, expression, loaded, data, delivery, mouse, mice, substrate, macrophages, lysates, nature, targeting, aan, tissue, incubated, treatment, peptide, activity, liposomal, supplementary, china, usa, active, aantatlipodox, site, control, human, antibody, group, represent, model,

Topics {✒️}

nature portfolio 2-dioleoyl-sn-glycero-3-phospho-ethanolamine-n-[methoxy permissions reprints carbobenzyloxy–alanine–alanine–asparagine–ethylenediamine–etoposide privacy policy plv-ef1α-legumain-ires-bsd plasmid plv-ef1α-luciferase-ires-bsd middle line represents legumain-specific substrate ala–ala–asn author information authors jandel scientific software fitc-labelled aan-tat-lipo-dox luciferase-expressing mda-mb-231 cells fitc-labelled aan-tat-lipo nanoparticles aan-tat-lipo-dox administration group aan-tat-lipo-dox treatment group advertising nature aan-tat-lipo carrying biomacromolecules aan-tat-nanoparticles sheds light aan-tat-lipo-dox group scripps research institute aan-tat-lipo nanoparticles produced aan-tat-lipo nanoparticle structure doxorubicin-loaded aan-tat-lipo nanoparticles social media oriented central-tumor delivery aan-tat-lipo-egfp group ala–ala–asn–amc41 dir-labelled aan-tat-lipo ala–ala–asn–amc mda-mb-231 mouse model 2-dioleoyl-sn-glycero-3-phosphoethanolamine 2-dioleoyl-sn-glycero-3-phosphocholine aan-tat-lipo carrier system aan-tat-lipo enhances internalization commercial substrate z-aan-amc tat-lipo-dox experimental groups aan-tat-lipo increases accumulation cleaves aan-tat-lipo luciferase-expressing a549 cells tat-lipo-dox treatment groups luciferase-expressing 4t1 cells legumain substrate z-aan-amc japan full access establishing stable legumain-expressing aan-tan-lipo nanoparticles luciferase-expressing cell lines aan-tat-lipo-dox

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment
         description:Specific targeting and cellular internalization are key properties for carriers of antitumor therapeutic agents. Here, we develop a drug carrier through the attachment of substrate of endoprotease legumain, alanine–alanine–asparagine (AAN), to cell-penetrating peptides (TAT, trans-activating factor). The addition of the AAN moiety to the fourth lysine in the TAT creates a branched peptide moiety, which leads to a decrease in the transmembrane transport capacity of TAT by 72.65%. Legumain efficiently catalyses the release of TAT-liposome from the AAN-TAT-liposome and thereby recovers the penetrating capacity of TAT. Doxorubicin carried by the AAN-TAT-liposome led to an increase in the tumoricidal effect of doxorubicin and a reduction in its systemic adverse effects in comparison with doxorubicin carried by a control delivery system. Thus, the specific targeting and high efficiency of this delivery platform offers a novel approach to limit the toxicity of anticancer agents as well as increasing their efficacy in cancer therapy. Legumain is a protease found expressed in tumour cells and may be useful in the specific targeting of chemotherapeutics to tumour cells. Here, the authors design nanoparticles that are loaded with doxorubicin and contain a legumain cleavage site; once the nanoparticles enter tumour cells legumain activity results in the release of doxorubicin.
         datePublished:2014-06-27T00:00:00Z
         dateModified:2014-06-27T00:00:00Z
         pageStart:1
         pageEnd:11
         sameAs:https://doi.org/10.1038/ncomms5280
         keywords:
            Drug delivery
            Targeted therapies
            Science
            Humanities and Social Sciences
            multidisciplinary
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Figa_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig5_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig6_HTML.jpg
         isPartOf:
            name:Nature Communications
            issn:
               2041-1723
            volumeNumber:5
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Ze Liu
               affiliation:
                     name:Medical School of Nankai University, 94 Weijin Road
                     address:
                        name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Min Xiong
               affiliation:
                     name:Medical School of Nankai University, 94 Weijin Road
                     address:
                        name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Junbo Gong
               affiliation:
                     name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road
                     address:
                        name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road, Tianjin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yan Zhang
               affiliation:
                     name:Medical School of Nankai University, 94 Weijin Road
                     address:
                        name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nan Bai
               affiliation:
                     name:Medical School of Nankai University, 94 Weijin Road
                     address:
                        name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yunping Luo
               affiliation:
                     name:Beijing Union Medical School, 5 Dong Dan San Tiao
                     address:
                        name:Department of Immunology, Beijing Union Medical School, 5 Dong Dan San Tiao, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Luyuan Li
               affiliation:
                     name:Medical School of Nankai University, 94 Weijin Road
                     address:
                        name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yuquan Wei
               affiliation:
                     name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University
                     address:
                        name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yanhua Liu
               affiliation:
                     name:Medical School of Nankai University, 94 Weijin Road
                     address:
                        name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xiaoyue Tan
               affiliation:
                     name:Medical School of Nankai University, 94 Weijin Road
                     address:
                        name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Rong Xiang
               affiliation:
                     name:Medical School of Nankai University, 94 Weijin Road
                     address:
                        name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment
      description:Specific targeting and cellular internalization are key properties for carriers of antitumor therapeutic agents. Here, we develop a drug carrier through the attachment of substrate of endoprotease legumain, alanine–alanine–asparagine (AAN), to cell-penetrating peptides (TAT, trans-activating factor). The addition of the AAN moiety to the fourth lysine in the TAT creates a branched peptide moiety, which leads to a decrease in the transmembrane transport capacity of TAT by 72.65%. Legumain efficiently catalyses the release of TAT-liposome from the AAN-TAT-liposome and thereby recovers the penetrating capacity of TAT. Doxorubicin carried by the AAN-TAT-liposome led to an increase in the tumoricidal effect of doxorubicin and a reduction in its systemic adverse effects in comparison with doxorubicin carried by a control delivery system. Thus, the specific targeting and high efficiency of this delivery platform offers a novel approach to limit the toxicity of anticancer agents as well as increasing their efficacy in cancer therapy. Legumain is a protease found expressed in tumour cells and may be useful in the specific targeting of chemotherapeutics to tumour cells. Here, the authors design nanoparticles that are loaded with doxorubicin and contain a legumain cleavage site; once the nanoparticles enter tumour cells legumain activity results in the release of doxorubicin.
      datePublished:2014-06-27T00:00:00Z
      dateModified:2014-06-27T00:00:00Z
      pageStart:1
      pageEnd:11
      sameAs:https://doi.org/10.1038/ncomms5280
      keywords:
         Drug delivery
         Targeted therapies
         Science
         Humanities and Social Sciences
         multidisciplinary
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Figa_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig5_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig6_HTML.jpg
      isPartOf:
         name:Nature Communications
         issn:
            2041-1723
         volumeNumber:5
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Ze Liu
            affiliation:
                  name:Medical School of Nankai University, 94 Weijin Road
                  address:
                     name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Min Xiong
            affiliation:
                  name:Medical School of Nankai University, 94 Weijin Road
                  address:
                     name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Junbo Gong
            affiliation:
                  name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road
                  address:
                     name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road, Tianjin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yan Zhang
            affiliation:
                  name:Medical School of Nankai University, 94 Weijin Road
                  address:
                     name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nan Bai
            affiliation:
                  name:Medical School of Nankai University, 94 Weijin Road
                  address:
                     name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yunping Luo
            affiliation:
                  name:Beijing Union Medical School, 5 Dong Dan San Tiao
                  address:
                     name:Department of Immunology, Beijing Union Medical School, 5 Dong Dan San Tiao, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Luyuan Li
            affiliation:
                  name:Medical School of Nankai University, 94 Weijin Road
                  address:
                     name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yuquan Wei
            affiliation:
                  name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University
                  address:
                     name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yanhua Liu
            affiliation:
                  name:Medical School of Nankai University, 94 Weijin Road
                  address:
                     name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xiaoyue Tan
            affiliation:
                  name:Medical School of Nankai University, 94 Weijin Road
                  address:
                     name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Rong Xiang
            affiliation:
                  name:Medical School of Nankai University, 94 Weijin Road
                  address:
                     name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Nature Communications
      issn:
         2041-1723
      volumeNumber:5
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Medical School of Nankai University, 94 Weijin Road
      address:
         name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
         type:PostalAddress
      name:Medical School of Nankai University, 94 Weijin Road
      address:
         name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
         type:PostalAddress
      name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road
      address:
         name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road, Tianjin, China
         type:PostalAddress
      name:Medical School of Nankai University, 94 Weijin Road
      address:
         name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
         type:PostalAddress
      name:Medical School of Nankai University, 94 Weijin Road
      address:
         name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
         type:PostalAddress
      name:Beijing Union Medical School, 5 Dong Dan San Tiao
      address:
         name:Department of Immunology, Beijing Union Medical School, 5 Dong Dan San Tiao, Beijing, China
         type:PostalAddress
      name:Medical School of Nankai University, 94 Weijin Road
      address:
         name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
         type:PostalAddress
      name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University
      address:
         name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
         type:PostalAddress
      name:Medical School of Nankai University, 94 Weijin Road
      address:
         name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
         type:PostalAddress
      name:Medical School of Nankai University, 94 Weijin Road
      address:
         name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
         type:PostalAddress
      name:Medical School of Nankai University, 94 Weijin Road
      address:
         name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Ze Liu
      affiliation:
            name:Medical School of Nankai University, 94 Weijin Road
            address:
               name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
               type:PostalAddress
            type:Organization
      name:Min Xiong
      affiliation:
            name:Medical School of Nankai University, 94 Weijin Road
            address:
               name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
               type:PostalAddress
            type:Organization
      name:Junbo Gong
      affiliation:
            name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road
            address:
               name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road, Tianjin, China
               type:PostalAddress
            type:Organization
      name:Yan Zhang
      affiliation:
            name:Medical School of Nankai University, 94 Weijin Road
            address:
               name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
               type:PostalAddress
            type:Organization
      name:Nan Bai
      affiliation:
            name:Medical School of Nankai University, 94 Weijin Road
            address:
               name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
               type:PostalAddress
            type:Organization
      name:Yunping Luo
      affiliation:
            name:Beijing Union Medical School, 5 Dong Dan San Tiao
            address:
               name:Department of Immunology, Beijing Union Medical School, 5 Dong Dan San Tiao, Beijing, China
               type:PostalAddress
            type:Organization
      name:Luyuan Li
      affiliation:
            name:Medical School of Nankai University, 94 Weijin Road
            address:
               name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
               type:PostalAddress
            type:Organization
      name:Yuquan Wei
      affiliation:
            name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University
            address:
               name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
               type:PostalAddress
            type:Organization
      name:Yanhua Liu
      affiliation:
            name:Medical School of Nankai University, 94 Weijin Road
            address:
               name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
               type:PostalAddress
            type:Organization
      name:Xiaoyue Tan
      affiliation:
            name:Medical School of Nankai University, 94 Weijin Road
            address:
               name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Rong Xiang
      affiliation:
            name:Medical School of Nankai University, 94 Weijin Road
            address:
               name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
      name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
      name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road, Tianjin, China
      name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
      name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
      name:Department of Immunology, Beijing Union Medical School, 5 Dong Dan San Tiao, Beijing, China
      name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
      name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
      name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
      name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
      name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(168)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Particles.js
  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {📦}

  • Crossref

4.89s.